A Phase I Study of Antisense Bcl-2 Oligonucleotide (G3139) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 12 Feb 2016
At a glance
- Drugs Oblimersen (Primary) ; Carboplatin; Paclitaxel
- Indications Solid tumours
- Focus Adverse reactions
- 01 Jun 2008 Status change from in progress to completed as reported by clinicaltrials.gov.
- 31 May 2008 The expected completion date for this trial was 1 May 2008 as reported by clinicaltrials.gov.
- 17 Aug 2005 New trial record.